loadpatents
name:-0.032401084899902
name:-0.042438983917236
name:-0.0044050216674805
Olson; Steven H. Patent Filings

Olson; Steven H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Olson; Steven H..The latest application filed is for "piperidinone derivatives as mdm2 inhibitors for the treatment of cancer".

Company Profile
4.27.29
  • Olson; Steven H. - Millbrae CA
  • Olson; Steven H. - Greer SC
  • Olson; Steven H. - Clark NJ
  • Olson; Steven H. - Metuchen NJ
  • Olson; Steven H. - Corona CA
  • Olson; Steven H. - Charlotte NC
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
Grant 11,407,721 - Bartberger , et al. August 9, 2
2022-08-09
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20220169611 - Bartberger; Michael D. ;   et al.
2022-06-02
Heteroaryl-substituted triazoles as APJ receptor agonists
Grant 11,046,680 - Chen , et al. June 29, 2
2021-06-29
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20210179560 - Bartberger; Michael D. ;   et al.
2021-06-17
Triazole furan compounds as agonists of the APJ receptor
Grant 10,736,883 - Brown , et al. A
2020-08-11
Triazole Furan Compounds As Agonists Of The Apj Receptor
App 20190275008 - BROWN; Matthew ;   et al.
2019-09-12
Triazole agonists of the APJ receptor
Grant 10,221,162 - Chen , et al.
2019-03-05
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20190062276 - Bartberger; Michael D. ;   et al.
2019-02-28
Cis-morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer
App 20180354918 - BARTBERGER; Michael D. ;   et al.
2018-12-13
Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor
Grant 10,150,760 - Chen , et al. Dec
2018-12-11
Triazole Agonists Of The Apj Receptor
App 20180319773 - CHEN; Ning ;   et al.
2018-11-08
Compounds For Use In Preparing Heterocyclic Triazole Agonists Of The Apj Receptor
App 20180222895 - Chen; Xiaoqi ;   et al.
2018-08-09
Heterocyclic triazole compounds as agonists of the APJ receptor
Grant 9,988,369 - Chen , et al. June 5, 2
2018-06-05
Triazole agonists of the APJ receptor
Grant 9,868,721 - Chen , et al. January 16, 2
2018-01-16
Intermediates for preparing triazole agonists of the APJ receptor
Grant 9,845,310 - Chen , et al. December 19, 2
2017-12-19
Heterocyclic Triazole Compounds As Agonists Of The Apj Receptor
App 20170320860 - CHEN; Xiaoqi ;   et al.
2017-11-09
Heteroaryl acid morpholinone compounds as MDM2 inhibitors for the treatment of cancer
Grant 9,758,495 - Gonzalez Buenrostro , et al. September 12, 2
2017-09-12
Methods for preparing triazole agonists of the APJ receptor
Grant 9,751,864 - Chen , et al. September 5, 2
2017-09-05
Triazole agonists of the APJ receptor
Grant 9,745,286 - Chen , et al. August 29, 2
2017-08-29
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20170144971 - BARTBERGER; Michael D. ;   et al.
2017-05-25
Triazole agonists of the APJ receptor
Grant 9,656,997 - Chen , et al. May 23, 2
2017-05-23
Intermediates for preparing triazole agonists of the APJ receptor
Grant 9,656,998 - Chen , et al. May 23, 2
2017-05-23
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
Grant 9,593,129 - Bartberger , et al. March 14, 2
2017-03-14
Triazole agonists of the APJ receptor
Grant 9,573,936 - Chen , et al. February 21, 2
2017-02-21
Triazole Agonists Of The Apj Receptor
App 20170042871 - Chen; Ning ;   et al.
2017-02-16
Triazole Agonists Of The Apj Receptor
App 20170042872 - CHEN; Ning ;   et al.
2017-02-16
Triazole Agonists Of The Apj Receptor
App 20170044131 - CHEN; Ning ;   et al.
2017-02-16
Triazole Agonists Of The Apj Receptor
App 20170042897 - Chen; Ning ;   et al.
2017-02-16
Triazole Agonists Of The Apj Receptor
App 20170037026 - CHEN; Ning ;   et al.
2017-02-09
Triazole Agonists Of The Apj Receptor
App 20170035744 - CHEN; Ning ;   et al.
2017-02-09
Triazole Agonists Of The Apj Receptor
App 20160340336 - Chen; Ning ;   et al.
2016-11-24
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
Grant 9,376,425 - Bartberger , et al. June 28, 2
2016-06-28
Pyrazole amide derivative
Grant 9,365,522 - Beck , et al. June 14, 2
2016-06-14
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20160137667 - BARTBERGER; Michael D. ;   et al.
2016-05-19
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
Grant 9,296,736 - Bartberger , et al. March 29, 2
2016-03-29
Heteroaryl Acid Morpholinone Compounds As Mdm2 Inhibitors For The Treatment Of Cancer
App 20160039774 - GONZALEZ BUENROSTRO; Ana ;   et al.
2016-02-11
Cis-morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer
App 20160002185 - BARTBERGER; Michael D. ;   et al.
2016-01-07
Pyrazole Amide Derivative
App 20150266824 - Beck; Hilary Plake ;   et al.
2015-09-24
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer
App 20140315895 - Bartberger; Michael D. ;   et al.
2014-10-23
Heterocyclic Compounds As Mdm2 Inhibitors For The Treatment Of Cancer
App 20140235629 - Bartberger; Michael D. ;   et al.
2014-08-21
Lowering And Raising A Single Wind Turbine Rotor Blade From Six-o'clock Position
App 20100139062 - Reed; Bryan P. ;   et al.
2010-06-10
11-.beta.-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
Grant 7,329,683 - Balkovec , et al. February 12, 2
2008-02-12
11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
Grant 7,179,802 - Olson , et al. February 20, 2
2007-02-20
Coumermycin analogs as chemical dimerizers of chimeric proteins
Grant 6,916,846 - Farrar , et al. July 12, 2
2005-07-12
11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
App 20050070720 - Balkovec, James M. ;   et al.
2005-03-31
11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
App 20040106664 - Olson, Steven H. ;   et al.
2004-06-03
11-.beta.-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
Grant 6,730,690 - Olson , et al. May 4, 2
2004-05-04
11-beta-hydroxysteroid Dehydrogenase 1 Inhibitors Useful For The Treatment Of Diabetes, Obesity And Dyslipidemia
App 20040048912 - Olson, Steven H. ;   et al.
2004-03-11
Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
App 20030207859 - Balkovec, James M. ;   et al.
2003-11-06
Substituted succinic acid metallo-.beta.-lactamase inhibitors and their use in treating bacterial infections
Grant 6,630,510 - Balkovec , et al. October 7, 2
2003-10-07
Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
App 20030078418 - Balkovec, James M. ;   et al.
2003-04-24
Coumermycin analogs as chemical dimerizers of chimeric proteins
App 20020095026 - Farrar, Michael A. ;   et al.
2002-07-18
Composite bicycle frame and method of manufacture
Grant 5,876,054 - Olson , et al. March 2, 1
1999-03-02
Composite bicycle frame and method of manufacturing
Grant 5,803,476 - Olson , et al. September 8, 1
1998-09-08
Bicycle frame
Grant D372,002 - Busby , et al. July 23, 1
1996-07-23
Single diaphragm forming of drapeable thermoplastic impregnated composite materials
Grant 5,037,599 - Olson August 6, 1
1991-08-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed